Abstract
This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.
Original language | English |
---|---|
Number of pages | 1 |
Journal | Journal of experimental & clinical cancer research : CR |
Volume | 37 |
Issue number | 1 |
DOIs | |
Publication status | Published - Oct 30 2018 |
Keywords
- Anti-tumor immune response
- CTLA-4
- Immune checkpoints
- Immunotherapy
- PD-1
- PD-L1
ASJC Scopus subject areas
- Oncology
- Cancer Research